Related references
Note: Only part of the references are listed.Therapeutic effect of nebulized hypertonic saline for muco-obstructive lung diseases: a systematic review and meta-analysis with trial sequential analysis
Yin Zhang et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2021)
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
Felix Ratjen et al.
LANCET RESPIRATORY MEDICINE (2019)
Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review
Luis Maiz Carro et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial
Beatriz Herrero-Cortina et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2018)
Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients
Luis Maiz et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2018)
Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis
Fiona Kellett et al.
RESPIRATORY MEDICINE (2011)
A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
MR Elkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis
F Kellett et al.
RESPIRATORY MEDICINE (2005)
Share Paper
